Core 4.0

C-PMI 1-2: Quality Management Program Structure and Oversight

Submited by: Tom Goddard

The Basics

Your organization must have a quality management committee ("QMC") that performs the following functions:

  • overseeing and guiding the QM program;
  • keeping tabs on the organization's progress in meeting its QM goals;
  • guides the staff on meeting the organization's QM goals;
  • approves the quality improvement projects ("QIPs"); and 
  • conducts a periodic evaluation of how effective the QM program is.
The QMC should be comprised of content experts as appropriate to the scope of the QM program and the current accreditation application. 

Management Tips

Naturally, the QMC need not be called "quality management committee": a QMC by any other name is still a QMC, at least as far as URAC is concerned. 
While you may staff the QMC exclusively with staffers, you may need to consider bringing in outside experts to ensure the presence of "content experts" as required by this standard. 
In addition to QIPs, the QMC should have a hand in the design, implementation, and oversight of Corrective Action Plans.
Be sure your QMC minutes describe the department affiliation of each attendee.

Accreditation Tips

Desktop Review
Submit the QM Program Description, which, presumably, describes the composition and activities of the QMC. We also recommend that you submit one or two examples of QMC committee meeting minutes and/or quality dashboards.
Validation Review
The reviewer will talk with both leadership and staff about the organization's QM program and the functioning of the QMC.
Document review
The reviewer will review in some detail the QMC's meeting minutes to see documented evidence that your committee complies fully with this standard's composition and activity requirements. If you have a QM dashboard, the reviewer will examine that, as well.

  • Specialty Pharmacy 3.1 / 03.25.2019

    SDrM 6 - Patient Safety Process Requirements

    This standard requires that your pharmacy maintain a robust program for addressing patient safety issues. That program needs to have the capability of:Identification and reporting of adverse drug events;Reporting such events to external entities (e.g., payers, MedWatch, PSO);Identification and management of risk;Disclosing clinically significant errors to affected patients and their caregivers;Ide...

  • Specialty Pharmacy 3.1 / 03.25.2019

    SDrM 5 – Drug Utilization Management Reporting

    This brief standard simply requires that your pharmacy has a mechanism by which it provides a report on the drug utilization management program to the quality management committee ("QMC") or some other committee that oversees quality management.The content of that report is up to the pharmacy, but URAC has an expectation that it will include such information as:The volume of utilization reviews, s...

  • Specialty Pharmacy 3.1 / 03.25.2019

    SDrM 4 – Prospective, Concurrent, and Retrospective Drug Management

    If your pharmacy is contracted to conduct prospective, concurrent, and retrospective reviews, it must implement policies that such reviews involve a consideration of, where appropriate, the following issues:Therapeutic appropriateness; Over and underutilization;Generic use;Therapeutic interchange;Duplication;Drug-disease contraindications;Drug-drug or drug-allergy interactions; Drug dosage;Duratio...